| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Nicorandil | Methyl nicotinate | VL3700005 | View CAS 93-60-7 |
| Nicorandil | Nicorandil EP Impurity A | VL3700001 | View CAS 65141-47-1 |
| Nicorandil | Nicorandil N 2 Hydroxy ethyl nicotinamide | VL3700003 | View CAS 6265-73-2 |
| Nicorandil | Nicornadil 2 amino ethyl nicotinate | VL3700004 | View CAS 87330-70-9 |
| Catalogue No. | VL3700003 |
| CAS No. | 6265-73-2 |
| Molecular Formula | C₈H₁₀N₂O₂ |
| Molecular Weight | 166.18 |
| Parent drug | Nicorandil |
| IUPAC Name | 3-(2-Hydroxyethyl)carbamoylpyridine |
| Synonyms | N/A |
| References | Mehta, Tushar N., et al. “Determination of Inorganic Nitrate Impurity from Nicorandil and Its Tablet Dosage Form by Simple Reversed Phase Liquid Chromatographic Method.” Journal of Chromatography A, vol. 1101, no. 1-2, Jan. 2006, pp. 153–57, https://doi.org/10.1016/j.chroma.2005.09.071.? Izumiya, Yasuhiro, et al. “Long-Term Use of Oral Nicorandil Stabilizes Coronary Plaque in Patients with Stable Angina Pecto |
| Status | In-stock |
| ListName | Nicorandil N 2 Hydroxy ethyl nicotinamide |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
